Stay updated on Efficacy of Dupilumab in EoE Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Dupilumab in EoE Clinical Trial page.

Latest updates to the Efficacy of Dupilumab in EoE Clinical Trial page
- Check2 days agoChange DetectedA new 2026 publication by Lim et al. about dupilumab normalizing the eosinophilic esophagitis transcriptome was added to the publications list, and a prior online-ahead-of-print citation for the same work was deleted, reflecting an update to the study's referenced literature.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a new publication citation for a 2026 Dupilumab pharmacokinetics study in EoE, and updated the page revision from v3.6.3 to v3.6.4.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe page shows a new revision tag: v3.6.3 replacing v3.6.2, signaling a minor site template update. This change does not affect the study details or visible content.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision: v3.6.2 replaced the previous v3.6.0 on the page. This reflects a minor maintenance update to the page’s underlying version and does not modify study details or displayed information.SummaryDifference0.0%

- Check59 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', and new navigation aids were added (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment header was adjusted and the revision label updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check66 days agoChange DetectedThe page shows a new Revision: v3.5.5, replacing Revision: v3.5.4. This appears to be a software/template update rather than a change to the study details.SummaryDifference0.0%

Stay in the know with updates to Efficacy of Dupilumab in EoE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Dupilumab in EoE Clinical Trial page.